Renalytix Plc (AIM:RENX)
London · Delayed Price · Currency is GBP · Price in GBX 4.078
-0.022 (-0.54%)
Aug 17, 2026, 3:49 PM GMT
Renalytix Market Cap
Renalytix has a market cap or net worth of 17.92 million as of August 17, 2026. Its market cap has decreased by -5.92% in one year.
Market Cap
17.92M
Enterprise Value
17.62M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.08
ChartMarket Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 17.92M, a decrease of -72.25%. That is a compound annual growth rate of -15.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 17.92M | -30.51% |
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 181.59B |
| GSK plc | 74.39B |
| Haleon | 31.53B |
| Smith & Nephew | 9.30B |
| genedrive | 19.27M |
| Inspiration Healthcare Group | 16.59M |
| RUA Life Sciences | 16.45M |
| IXICO | 16.35M |